Palantir Down This Collapse: Is It Worth a Buy Now?
Palantir stock slides further from its 52-week high even after a standout Q4, as investors weigh a rich valuation aga...
Understanding TR indices helps investors gauge real performance by including income. This primer covers definitions, uses, and limitations for smarter choices.
27,608 articlesPalantir stock slides further from its 52-week high even after a standout Q4, as investors weigh a rich valuation aga...
Northrop Grumman has surged in 2026 on a record backlog and strong cash flow, but a major program in limbo keeps inve...
Apple faces a window of opportunity as upbeat quarterly results and expanding services/supporting growth drivers push...
Core Scientific reports higher first-quarter revenue and gross profit, yet a net loss due to impairment charges derai...
SVB Capital, the bank's roughly $10 billion venture arm, is being shopped as regulators unwind SVB assets. Buyers are...
Hedge fund veteran Michael Burry has added stakes in a high-dividend pharma name and a leading oilfield services comp...
Target delivered a solid beat-and-raise quarter, yet shares slid, illustrating a sell-the-news dynamic. With Walmart ...
The levered BOIL ETF aims for double daily moves in natural gas, but ongoing contango and roll costs erode value for ...
Dell Technologies stunned markets with a Q1 FY27 results beat, led by AI-optimized servers and a rising backlog. The ...
A $970,000 portfolio built for steady distributions could potentially exceed the Atlanta metro median income, but suc...
A decade of gains has transformed a modest Microsoft stake into a multithousand-dollar position for some investors, f...
As IPO chatter heats up in 2026, SpaceX faces a pivotal moment. The CFO’s quiet leadership could define the deal, unl...